| Followers | 74 |
| Posts | 3928 |
| Boards Moderated | 0 |
| Alias Born | 03/23/2013 |
Monday, November 14, 2022 12:48:21 PM
iwander -
But what happened to your promised 10% haircut last week. Instead it grew +12%.. And what about your "picture is worth a thousand words"? LOL
hahaha... too funny. You terrorized longs for "looking forward" when the trend was against them. Remember, you said you were so "intrigued"?
Now you are shorting into a bottom squeeze pattern and "looking forward" to lower prices, blinded by the bullish pattern (just the inverse). Thank you for making this trade because it adds fuel to the upside!
not for long. Today is the 1 step back before 2-4 steps forward - and expected on options settlement day. The 'Golden Cross' will occur after the close today. Then price will begin to target the 200MA .
I'm "looking forward" to a close @1.35 or higher
Are you like the other poster who said his "common sense TA" said we'd trade "weakly and down" for the rest of the week (when we traded up 12%) and that he would admit if he was wrong?
I'm looking forward to making at least $10K+ with my AMRN PUNK short position this week
But what happened to your promised 10% haircut last week. Instead it grew +12%.. And what about your "picture is worth a thousand words"? LOL
hahaha... too funny. You terrorized longs for "looking forward" when the trend was against them. Remember, you said you were so "intrigued"?
Now you are shorting into a bottom squeeze pattern and "looking forward" to lower prices, blinded by the bullish pattern (just the inverse). Thank you for making this trade because it adds fuel to the upside!
I'm already GREEN this morning.
not for long. Today is the 1 step back before 2-4 steps forward - and expected on options settlement day. The 'Golden Cross' will occur after the close today. Then price will begin to target the 200MA .
I'm "looking forward" to a close @1.35 or higher
Are you like the other poster who said his "common sense TA" said we'd trade "weakly and down" for the rest of the week (when we traded up 12%) and that he would admit if he was wrong?
Recent AMRN News
- Earnings Report Shows Narrowing Losses as Amarin (AMRN) Advances Partner-Led Growth Strategy • IH Market News • 04/29/2026 02:19:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/29/2026 11:06:34 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/29/2026 11:05:15 AM
- Amarin Reports 2026 First Quarter Financial Results • GlobeNewswire Inc. • 04/29/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/22/2026 09:00:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:02 PM
- Amarin to Report First Quarter 2026 Financial Results and Host Conference Call on April 29, 2026 • GlobeNewswire Inc. • 04/15/2026 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/10/2026 09:01:34 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/10/2026 09:00:20 PM
- American College of Cardiology (ACC) Scientific Sessions 2026 Underscore the Need for Complementary Therapies Including Icosapent Ethyl (IPE) in Treatment of Elevated Triglycerides and Cardiovascular Risk Reduction • GlobeNewswire Inc. • 04/08/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:30:11 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/30/2026 09:57:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 09:00:07 PM
- Amarin Highlights Guideline Recommended Role of Icosapent Ethyl in Managing Cardiovascular Risk Following Release of Updated 2026 ACC/AHA/Multisociety Dyslipidemia Guideline • GlobeNewswire Inc. • 03/18/2026 12:30:00 PM
- New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual Scienti • GlobeNewswire Inc. • 03/16/2026 12:15:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/02/2026 10:31:01 PM
- Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-IT® Post Hoc Analysis Published in the European Journal of Preventive Cardiology • GlobeNewswire Inc. • 03/02/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 12:05:26 PM
- Amarin Reports Fourth Quarter and Full Year 2025 Financial Results • GlobeNewswire Inc. • 02/25/2026 12:00:00 PM
- This American Heart Month Amarin Spotlights the Need to Prioritize Proven Widely Available Yet Underutilized Therapies in the Battle Against Cardiovascular Disease • GlobeNewswire Inc. • 02/23/2026 01:00:00 PM
